DEVELOPMENT OF THE OPTIMAL CONDITIONS FOR ISOLATION AND ANALYSIS OF TARTRAZINE IN SOLID DOSAGE FORMS
PDF

How to Cite

Sivsivadze, K., Chomakhashvili, K., Murtazashvili, T., Jokhadze, M., & Tatanashvili, M. (2023). DEVELOPMENT OF THE OPTIMAL CONDITIONS FOR ISOLATION AND ANALYSIS OF TARTRAZINE IN SOLID DOSAGE FORMS. Collection of Scientific Works of Tbilisi State Medical University, 56, 130–134. Retrieved from https://journals.4science.ge/index.php/CSW/article/view/2297

Abstract

The aim of the present study was to develop optimal conditions for qualitative and quantitative analysis of some color agents (dyes) in solid drug forms. It is necessary to develop methods of analysis of high sensitivity and accuracy for the analysis of dyes, as they have certain regulations and analysis methods are not found in the available literature. Optimal conditions for isolation of tartrazine from tablet (solvent system - ethyl alcohol 50%), double isolation for 10 minutes) are developed, which provides effective isolation from tartrazine tablet (degree of isolation 93%). Optimal conditions of liquid chromatographic-tandem mass spectrometric method of qualitative-quantitative analysis of tartrazine in the tablet are developed. Rolling phase 0.1% formic acid: Acetonitrile - 0.1% formic acid: water (60:40), system isocratic, column temperature - 30o C, collision energy 100 EV, ionization positive (ESI +), multi-reaction monitoring mode (MRM). Validity parameters are set, the method is distinguished by linearity (caliber concentration 100.0 - 1000.0 ng / ml, correlation coefficient - R2 = 0.9984), selectivity, low detection minimum (100.23 ng / ml) and determinable minimum (201.68 ng / ml).

PDF

References

ბაკურიძე ა, წამალთა ტექნოლოგია, გამომცემლობა ,,ირიდა’’, თბილისი, 2009 წ

Abbey J., Tomaska L.D., Hazards and Diseases, Encyclopedia of Food Safety, 2014 ì.

Alsop T, Forecast number of tablet users worldwide 2013-2021, Statista, Feb, 2022

CFR Title 21 Part 70: Color Additive Regulations, FDA,March 22, 1977, retrieved February 15, 2012

Current EU approved additives and their E Numbers,Food Standards Agency website, retrieved 15 Dec 2011

Elhkim MO, Héraud F, Bemrah N, et al., “New considerations regarding the risk assessment on Tartrazine: An update toxicological assessment, intolerance reactions and maximum theoretical daily intake in France”. Regulatory Toxicology and Pharmacology. 47 (3), April 2007

European Parliament and Council Directive 94/36/EC of 30 June 1994 on colours for use in foodstuffs

FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES, CFR - Code of Federal Regulations Title 21, FOOD AND DRUGS, CHAPTER I, PART 70, COLOR ADDITIVES, March 2022

Food Standards Australia New Zealand. “Food Additives- Numerical List”. Archived from the original on June 25, 2009. Retrieved 2 December 2009

Kanetkar A, EUROPEAN PHARMACEUTICAL REVIEW, April 2020

R. Christian Moreton, David R. Schoneker, Brian Carlin, Phyllis Walsh, Linda A. Herzog, George Collins, Priscilla Zawislak, Joseph Zeleznik, The Real Complexity of Excipient Composition, Pharmaceutical Technology, Volume 41, Issue 10, 2017

Rowe R.C, Sheskey P.J, Quinn M.E, Handbook of Pharmaceutical Excipients Sixth edition, Pharmaceutical Press and American Pharmacists Association, 2009

Sabnis, R. W. Handbook of Biological Dyes and Stains:Synthesis and Industrial Applications. Hoboken, NJ: Wiley,2010

Taylor S.L., Baumert J.L, Food Toxicology in Encyclopedia of Agriculture and Food Systems, 2014

Tovey G.D., Pharmaceutical Formulation, The Science and Technology of Dosage Forms, CPI Group (UK) Ltd, UK,

VAMSHI ALLAM K et all, COLORANTS - THE COSMETICS FOR THE PHARMACEUTICAL DOSAGE FORMS,International Journal of Pharmacy and Pharmaceutical Sciences, 2011

Downloads

Download data is not yet available.